Matching placebo to K-757 and matching placebo to K-833 for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Aug 2023: Trial registered, NCT06019559
  2. 15 Sep 2023: Trial started, NCT06019559

The trials

NCT06019559: A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833

State
Completed
Phase
Phase 2
People
155 taking part
Started
15 Sep 2023
Primary completion
7 Feb 2024
Arms
Placebo to K-757 and K-833
Results
Posted on the registry
  1. 31 Aug 2023: Trial registered
  2. 15 Sep 2023: Trial started
  3. 19 Feb 2024: Trial completed
  4. 26 Feb 2025: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.